IL10 and infection: However, further studies with larger study populations are needed to confirm our finding of higher ex vivo release of IL-10/higher circulating levels of IL-10 in patients with SARS-CoV-2 vaccine breakthrough infection and to determine the potential influence of this phenomenon on the COVID-19 disease course.